UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effects of PCSK-9 Inhibition by Alirocumab Treatments on Biliary Cirrhotic Rats

International journal of molecular sciences, 2022-07, Vol.23 (13), p.7378

2022

Volltextzugriff (PDF)

Fructooligosaccharides reverses hepatic vascular dysfunction and dysbiosis in rats with liver cirrhosis and portal hypertension

European journal of clinical investigation, 2024-11, Vol.54 (11), p.e14287

2024

Volltextzugriff (PDF)

Impact of HCV eradication on recurrence pattern and long‐term outcomes in patients with HCV‐related hepatocellular carcinoma undergoing radiofrequency ablation

Alimentary pharmacology & therapeutics, 2024-10, Vol.60 (7), p.940-952

2024

Volltextzugriff (PDF)

Endoscopic variceal ligation versus propranolol for the primary prevention of oesophageal variceal bleeding in patients with hepatocellular carcinoma: an open-label, two-centre, randomised controlled trial

Gut, 2023-12, Vol.73 (4), p.682-690

2023

Volltextzugriff (PDF)

Matrix metalloproteinase‐9 inhibition or deletion attenuates portal hypertension in rodents

Journal of cellular and molecular medicine, 2021-11, Vol.25 (21), p.10073-10087

2021

Volltextzugriff (PDF)

Glycyrrhizin Attenuates Portal Hypertension and Collateral Shunting via Inhibition of Extrahepatic Angiogenesis in Cirrhotic Rats

International journal of molecular sciences, 2021-07, Vol.22 (14), p.7662

2021

Volltextzugriff (PDF)

Caffeine ameliorates hemodynamic derangements and portosystemic collaterals in cirrhotic rats

Hepatology (Baltimore, Md.), 2015-05, Vol.61 (5), p.1672-1684

2015

Volltextzugriff (PDF)

Synthesis, characterization, and biological verification of asialoglycoprotein receptor-targeted lipopolysaccharide-encapsulated PLGA nanoparticles for the establishment of a liver fibrosis animal model

Biomaterials science, 2023-09, Vol.11 (19), p.665-6662

2023

Volltextzugriff (PDF)

Glucobrassicin Metabolites Ameliorate the Development of Portal Hypertension and Cirrhosis in Bile Duct-Ligated Rats

International journal of molecular sciences, 2019-08, Vol.20 (17), p.4161

2019

Volltextzugriff (PDF)

Effects of Caffeine Treatment on Hepatopulmonary Syndrome in Biliary Cirrhotic Rats

International journal of molecular sciences, 2019-03, Vol.20 (7), p.1566

2019

Volltextzugriff (PDF)

Enhanced Meningeal Lymphatic Drainage Ameliorates Neuroinflammation and Hepatic Encephalopathy in Cirrhotic Rats

Gastroenterology (New York, N.Y. 1943), 2021-03, Vol.160 (4), p.1315-1329.e13

2021

Volltextzugriff (PDF)

Dual Angiotensin Receptor and Neprilysin Inhibitor Ameliorates Portal Hypertension in Portal Hypertensive Rats

Pharmaceutics, 2020-04, Vol.12 (4), p.320

2020

Volltextzugriff (PDF)

Microsatellite Instability, Epstein-Barr Virus, and Programmed Cell Death Ligand 1 as Predictive Markers for Immunotherapy in Gastric Cancer

Cancers, 2022-01, Vol.14 (1), p.218

2022

Volltextzugriff (PDF)

Systemic treatments in pancreatic cancer: Taiwan pancreas society recommendation

Biomedical Journal, 2024-06, Vol.47 (3), p.100696, Article 100696

2024

Volltextzugriff (PDF)

Endothelin receptor blockers reduce shunting and angiogenesis in cirrhotic rats

European journal of clinical investigation, 2016-06, Vol.46 (6), p.572-580

2016

Volltextzugriff (PDF)

NAFLD Aggravates Septic Shock Due to Inadequate Adrenal Response and 11β-HSDs Dysregulation in Rats

Pharmaceutics, 2020-04, Vol.12 (5), p.403

2020

Volltextzugriff (PDF)

2'-Hydroxyflavanone ameliorates mesenteric angiogenesis and portal-systemic collaterals in rats with liver fibrosis

Journal of gastroenterology and hepatology, 2016-05, Vol.31 (5), p.1045-1051

2016

Volltextzugriff (PDF)

Microbiota transplants from feces or gut content attenuated portal hypertension and portosystemic collaterals in cirrhotic rats

Clinical science (1979), 2021-12, Vol.135 (24), p.2709-2728

2021

Volltextzugriff (PDF)

The influence of sorafenib on hepatic encephalopathy and the mechanistic survey in cirrhotic rats

European journal of clinical investigation, 2012-12, Vol.42 (12), p.1309-1316

2012

Volltextzugriff (PDF)

Nonalcoholic fatty liver disease and hepatocellular carcinoma: Distinct links

Journal of the Chinese Medical Association, 2021-08, Vol.84 (8), p.737-738

2021

Volltextzugriff (PDF)

Sodium-Glucose Cotransporter-2 Inhibition Exacerbates Hepatic Encephalopathy in Biliary Cirrhotic Rats

The Journal of pharmacology and experimental therapeutics, 2022-10, Vol.383 (1), p.25-31

2022

Volltextzugriff (PDF)

Low-dose alcohol exacerbates hyperdynamic circulation and shunting in non-alcoholic cirrhotic rats

Bioscience reports, 2024-07, Vol.44 (7)

2024

Volltextzugriff (PDF)

Hepatic encephalopathy: From novel pathogenesis mechanism to emerging treatments

Journal of the Chinese Medical Association, 2024-03, Vol.87 (3), p.245-251

2024

Volltextzugriff (PDF)

α-Adrenergic blockade prevented environmental temperature reduction-induced transient portal pressure surge in cirrhotic and portal hypertensive rats

Clinical science (1979), 2022-10, Vol.136 (20), p.1449-1466

2022

Volltextzugriff (PDF)

Dual angiotensin receptor and neprilysin inhibitor reduced portal pressure through peripheral vasodilatation and decreasing systemic arterial pressure in cirrhotic rats

Journal of the Chinese Medical Association, 2023-09, Vol.86 (9), p.786-794

2023

Volltextzugriff (PDF)

1 – 25 von 64

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(62)
Mit Volltextzugriff
(47)

Publikationsform

Sprache

Englisch
(64)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effects of PCSK-9 Inhibition by Alirocumab Treatments on Biliary Cirrhotic Rats

Fructooligosaccharides reverses hepatic vascular dysfunction and dysbiosis in rats with liver cirrhosis and portal hypertension

Impact of HCV eradication on recurrence pattern and long‐term outcomes in patients with HCV‐related hepatocellular carcinoma undergoing radiofrequency ablation

Endoscopic variceal ligation versus propranolol for the primary prevention of oesophageal variceal bleeding in patients with hepatocellular carcinoma: an open-label, two-centre, randomised controlled trial

Matrix metalloproteinase‐9 inhibition or deletion attenuates portal hypertension in rodents

Glycyrrhizin Attenuates Portal Hypertension and Collateral Shunting via Inhibition of Extrahepatic Angiogenesis in Cirrhotic Rats

Caffeine ameliorates hemodynamic derangements and portosystemic collaterals in cirrhotic rats

Synthesis, characterization, and biological verification of asialoglycoprotein receptor-targeted lipopolysaccharide-encapsulated PLGA nanoparticles for the establishment of a liver fibrosis animal model

Glucobrassicin Metabolites Ameliorate the Development of Portal Hypertension and Cirrhosis in Bile Duct-Ligated Rats

Effects of Caffeine Treatment on Hepatopulmonary Syndrome in Biliary Cirrhotic Rats

Enhanced Meningeal Lymphatic Drainage Ameliorates Neuroinflammation and Hepatic Encephalopathy in Cirrhotic Rats

Dual Angiotensin Receptor and Neprilysin Inhibitor Ameliorates Portal Hypertension in Portal Hypertensive Rats

Microsatellite Instability, Epstein-Barr Virus, and Programmed Cell Death Ligand 1 as Predictive Markers for Immunotherapy in Gastric Cancer

Systemic treatments in pancreatic cancer: Taiwan pancreas society recommendation

Endothelin receptor blockers reduce shunting and angiogenesis in cirrhotic rats

NAFLD Aggravates Septic Shock Due to Inadequate Adrenal Response and 11β-HSDs Dysregulation in Rats

2'-Hydroxyflavanone ameliorates mesenteric angiogenesis and portal-systemic collaterals in rats with liver fibrosis

Microbiota transplants from feces or gut content attenuated portal hypertension and portosystemic collaterals in cirrhotic rats

The influence of sorafenib on hepatic encephalopathy and the mechanistic survey in cirrhotic rats

Nonalcoholic fatty liver disease and hepatocellular carcinoma: Distinct links

Sodium-Glucose Cotransporter-2 Inhibition Exacerbates Hepatic Encephalopathy in Biliary Cirrhotic Rats

Low-dose alcohol exacerbates hyperdynamic circulation and shunting in non-alcoholic cirrhotic rats

Hepatic encephalopathy: From novel pathogenesis mechanism to emerging treatments

α-Adrenergic blockade prevented environmental temperature reduction-induced transient portal pressure surge in cirrhotic and portal hypertensive rats

Dual angiotensin receptor and neprilysin inhibitor reduced portal pressure through peripheral vasodilatation and decreasing systemic arterial pressure in cirrhotic rats

Suchergebnisse filtern